New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2014
10:02 EDTLOGI, CLR, BDN, SHW, BBT, YUM, VAR, STJ, JNJ, COF, BDX, GLUU, LULU, PRGO, UNH, PLL, CVD, BRO, AJG, LMT, MGM, ABV, WDAY, STIOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Arthur J. Gallagher (AJG) upgraded to Overweight from Equal Weight at Barclays... Becton Dickinson (BDX) upgraded to Neutral from Underperform at BofA/Merrill... Brandywine Realty (BDN) upgraded to Outperform from Market Perform at Raymond James... Brown & Brown (BRO) upgraded to Overweight from Equal Weight at Barclays... Capital One (COF) upgraded to Conviction Buy from Buy at Goldman... Continental Resources (CLR) upgraded to Buy from Neutral at BofA/Merrill... Covance (CVD) upgraded to Buy from Hold at Jefferies... Johnson & Johnson (JNJ) upgraded to Outperform from Sector Perform at RBC Capital... Logitech (LOGI) upgraded to Equal Weight from Underweight at Barclays... Pall Corp. (PLL) upgraded to Buy from Neutral at BofA/Merrill... St. Jude Medical (STJ) upgraded to Sector Perform from Underperform at RBC Capital... SunTrust (STI) upgraded to Outperform from Market Perform at BMO Capital... UnitedHealth (UNH) upgraded to Buy from Hold at Deutsche Bank... Varian Medical (VAR) upgraded to Neutral from Sell at Citigroup... Workday (WDAY) upgraded to Buy from Neutral at UBS... Yum! Brands (YUM) upgraded to Top Pick from Outperform at RBC Capital... Perrigo (PRGO) upgraded to Buy from Neutral at BofA/Merrill... AmBev (ABV) upgraded to Overweight from Equal Weight at Morgan Stanley... lululemon (LULU) upgraded to Buy from Neutral at DA Davidson... MGM Resorts (MGM) upgraded to Overweight from Equal Weight at Morgan Stanley... Glu Mobile (GLUU) upgraded to Buy from Hold at Craig-Hallum... BB&T (BBT) upgraded to Overweight from Neutral at JPMorgan... Sherwin-Williams (SHW) upgraded to Buy from Hold at KeyBanc... Lockheed Martin (LMT) upgraded to Buy from Neutral at BofA/Merrill.
News For AJG;BDX;BDN;BRO;COF;CLR;CVD;JNJ;LOGI;PLL;STJ;STI;UNH;VAR;WDAY;PRGO;YUM;ABV;LULU;BBT;MGM;GLUU;SHW;LMT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
December 8, 2014
11:48 EDTSTISunTrust downgraded to Hold from Buy at Standpoint Research
10:42 EDTGLUUGlu Mobile director buys 274K shares of company stock
Lorne Abony, a director of Glu Mobile disclosed in a filing this morning the purchase of 274,050 shares of company stock on December 4 and 5. shares of Glu Mobile are higher by over 7% in morning trading.
09:13 EDTYUMYum! Brands to host analyst and investor meeting
Subscribe for More Information
08:31 EDTBDXBecton Dickinson and CareFusion sets date for special meeting in proposed merger
Becton, Dickinson (BDX) and CareFusion (CFN) announced that CareFusion expects to hold a special meeting on January 21, 2015 for CareFusion stockholders to consider and vote upon the proposed merger of CareFusion and BD. As previously announced on October 5, 2014, BD and CareFusion entered into a definitive agreement pursuant to which BD would acquire CareFusion in a stock and cash transaction. CareFusion stockholder approval is a condition to the merger. In addition to CareFusion stockholder approval, the proposed acquisition remains subject to certain other conditions and approvals, including approval of the proposed acquisition by the European Commission under the European Union Merger Regulation. CareFusion has fixed the close of business on December 18, 2014 as the record date for the purpose of determining the stockholders who are entitled to notice of, and to vote at, the special meeting.
06:46 EDTYUMYum! Brands coverage resumed with a Sell at Goldman
Subscribe for More Information
06:12 EDTLULUStocks with implied volatility above IV index mean; LULU ACHN
Stocks with implied volatility above IV index mean; lululemon (LULU) 53, Achillion (ACHN) 216 according to iVolatility.
December 7, 2014
14:54 EDTJNJIMBRUVICA data suggests promise in multiple myeloma
Subscribe for More Information
December 5, 2014
15:49 EDTBDXBecton Dickinson, Aethon announce collaboration
Subscribe for More Information
13:26 EDTBBTComerica, BB&T, KeyCorp seen as potential activist targets, TheStreet says
The co-founder of PL Capital, Richard Lashley, expects shareholder activism to move from community banks to larger regional banks, including lenders like Comerica (CMA), BB&T Corp. (BBT), and KeyCorp (KEY), reported TheStreet, citing comments made during a panel on investment strategy during The Deal Economy Event at the Nasdaq Exchange. After the next presidential cycle, "When stress tests are done, when Basel is settled, and Congress will realize [the banks] have too much capital," Lashley expects more M&A in the sector, TheStreet quoted him as saying. Reference Link
10:00 EDTLMTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:56 EDTLMTLockheed Martin downgraded at Bernstein
As noted earlier, Bernstein downgraded Lockheed Martin to Market Perform from Outperform. The firm downgraded the stock on valuation. Target $208.
06:53 EDTLMTLockheed Martin downgraded to Market Perform from Outperform at Bernstein
05:55 EDTBDXCDC data postiive for flu testing companies, says Piper Jaffray
Subscribe for More Information
05:19 EDTAJGArthur J. Gallagher acquires Blue Holdings, terms not disclosed
Arthur J. Gallagher announced the acquisition of Blue Holdings based in Brisbane, Queensland, Australia. Terms of the transaction were not disclosed. Blue's CEO Richard Smith and his associates will continue to operate from their Brisbane, Perth, Sydney, Melbourne and Townsville locations under the direction of Andrew Godden, head of Gallagher's Australian brokerage operation.
December 4, 2014
15:56 EDTBROBrown & Brown COO Linda Downs to step down, effective December 31
On December 3, Linda S. Downs, COO of Brown & Brown, advised the company of her desire to step down from the position of COO of the company effective December 31, and the company and Downs agreed that she will cease service as COO of the company effective that date. Downs will continue to serve thereafter as an Executive Vice President of the company and as a member of the companyís Executive Leadership Team. The company has no current plans to appoint a replacement COO.
14:21 EDTLULULululemon Athletica volatility elevated into Q3 and outlook
Subscribe for More Information
11:23 EDTJNJAppeals court reverses patent ruling in favor of J&J unit over Covidien
Ethicon Endo-Surgery, a Johnson & Johnson (JNJ) company, appealed a district court judgment regarding certain asserted patent claims of Tyco Healthcare. The appeals court affirmed-in-part, reversed-in-part, and vacated-in-part the prior judgment, because the lower courtís 102(g) findings were correct, but its 103 determination was improper, "including its decision to exclude the 102(g) prior art from the obviousness analysis," the court stated. In 2007, Tyco Healthcare changed its name to Covidien (COV). Reference Link
09:01 EDTJNJVA negotiated $594 per dose price for Gilead HCV treatment
A Veterans Health Administration official told a Senate committee yesterday that Veterans' Affairs has "moved rapidly to deploy new, more effective, less toxic HCV treatments and has been able to negotiate significant discounts for these newer therapies." The agency negotiated a price of $594 per dose for Gilead's (GILD) Hepatitis C virus drug Sofosbuvir, below the commercial price of $1,000 per dose, VHA Chief Consultant for Pharmacy Benefits Management Michael Valentino told the Senate's Committee on Veterans' Affairs. The agency also received a $413 per dose price for Johnson & Johnson's (JNJ) Simeprevir, below the commerical price of $790. The VA has approximately 174,000 veterans in care with HCV, making it the largest single HCV provider in the U.S., Valentino pointed out. He added, "Like the rest of the country, VA has treated only a portion of Veterans for HCV because treatment and cures have been difficult to achieve due to low efficacy and high toxicity of standard drug therapies." Reference Link
08:40 EDTLULUlululemon coverage assume with an Outperform at Wedbush
Wedbush assumed coverage on lululemon with an Outperform rating from a Neutral rating and $57 price target. The firm sees shares moving higher from catalysts that include improving top line trends and comps, margin uside form seasonal products and supply chain efficiencies, international growth, and M&A speculation.
08:36 EDTCOFCapital One and Hudson's Bay Company sign new credit card program agreement
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use